Trademark Search in Canada

SKYTROFA

View On IC.GC.CA

REGISTERED

on 12 Feb 2024

Last Applicant/ Owned by

ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S

Tuborg Boulevard 12DK-2900 Hellerup

Serial Number

2111359 filed on 19^th Feb 2021

Registration Number

TMA1221205 registered on 12^th Feb 2024

Registration expiry Date

19^th Feb 2031

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

1800 - 510 West Georgia StreetVancouver

BRITISH COLUMBIA

V6B0M3

SKYTROFA

Trademark usage description

pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders, gro Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncology, ophthalmology, infectious diseases and disorders namely, Intestinal infectious diseases, Infections with a predominantly sexual mode of transmission, Viral infections of the central nervous system, Arthropod-borne viral fevers and viral haemorrhagic fevers, Viral infections characterized by skin and mucous membrane lesions, Human immunodeficiency virus [HIV] disease, Mycoses, Protozoal diseases, Helminthiases, enzyme replacement therapy for the treatment of lysosomal storage diseases, anti-inflammatory disease, pain, namely, for the relief of pain and for the treatment of chronic pain, respiratory system disorder, autoimmune disorders, vaccines for human and veterinary use , non-alcoholic steatohepatitis, psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, bone diseases, CNS diseases, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, myopathies, namely, muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy and cachexia and metabolic diseases of muscle, metabolic myopathies, mintochondria myopathies namely, muscular dystrophy, mucopolysaccharideoses, and cancer, obesity, wound healing, the hormonal system, namely growth hormone deficiency, diabetes and angiogenesis, the ophthalmological system, namely angiogenesis, the angiogenic system, the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system, the metabolic system, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system, namely, growth hormone deficiency, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; diagnostic preparations for identification and proof of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor (FGFR)-related skeletal disorders, oncology, ophthalmology, infectious diseases and disorders namely, Intestinal infectious diseases, Infections with a predominantly sexual mode of transmission, Viral infections of the central nervous system, Arthropod-borne viral fevers and viral haemorrhagic fevers, Viral infections characterized by skin and mucous membrane lesions, Human immunodeficiency virus [HIV] disease, Mycoses, Protozoal diseases, Helminthiases, lysosomal storage diseases, anti-inflammatory disease, pain, respiratory system disorders, autoimmune disorders, non-alcoholic steatohepatitis, psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, bone diseases, CNS diseases, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, myopathies, namely, muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy and cachexia and metabolic diseases of muscle, metabolic myopathies, mintochondria myopathies namely, muscular dystrophy, mucopolysaccharideoses, and cancer, obesity, the hormonal system, namely growth hormone deficiency, diabetes and angiogenesis, the ophthalmological system, namely angiogenesis, the angiogenic system, the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system, the metabolic system, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system, namely, growth hormone deficiency, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases.

Classification kind code

Class [010]
Medical devices for injection, dosage and control of pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncology, ophthalmology, infectious diseases and disorders namely, Intestinal infectious diseases, Infections with a predominantly sexual mode of transmission, Viral infections of the central nervous system, Arthropod-borne viral fevers and viral haemorrhagic fevers, Viral infections characterized by skin and mucous membrane lesions, Human immunodeficiency virus [HIV] disease, Mycoses, Protozoal diseases, Helminthiases, enzyme replacement therapy for the treatment of lysosomal storage diseases, anti-inflammatory disease, pain, namely, for the relief of pain and for the treatment of chronic pain, respiratory system disorder, autoimmune disorders, vaccines for human and veterinary use , non-alcoholic steatohepatitis, psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, bone diseases, CNS diseases, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, myopathies, namely, muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy and cachexia and metabolic diseases of muscle, metabolic myopathies, mintochondria myopathies namely, muscular dystrophy, mucopolysaccharideoses, and cancer, obesity, wound healing, the hormonal system, namely growth hormone deficiency, diabetes and angiogenesis, the ophthalmological system, namely angiogenesis, the angiogenic system, the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system, the metabolic system, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system, namely, growth hormone deficiency, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical use, namely syringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with treatment of growth hormone disorders, hypoparathyroidism, skeletal dysplasia, cancer and diabetes; medical infusion and injection devices for administering drugs; apparatus and instruments for diagnostic purposes, namely, dosage management dispensers for medicines, containing software for medical information management for use in web-based physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic.

Classification kind code

Mark Details

Serial Number

2111359

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 27^th Jan 2023	Agent Changed
Submitted for opposition 22 on 7^th Sept 2022	Search Recorded
Submitted for opposition 20 on 7^th Sept 2022	Examiner's First Report
Submitted for opposition 223 on 7^th Sept 2022	Total Provisional Refusal
Submitted for opposition 256 on 4^th Apr 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 3^rd Jun 2021	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 3^rd Jun 2021	Formalized
Submitted for opposition 1 on 2^th Jun 2021	Created
Submitted for opposition 228 on 19^th Feb 2021	International Registration
Submitted for opposition 30 on 19^th Feb 2021	Filed